Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Atsushi Horiike
Observed names:
A. Horiike,
Horiike Atsushi
Institution:
SHOWA Medical University
Observed institutions:
SHOWA Medical University,
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research,
National Cancer Center Hospital
ORCID:
0000-0001-6941-7494
Observed ORCID:
0000-0001-6941-7494
OpenAlex ID:
A5037192053
PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
2019
·
A. Drilon
, G. Oxnard
, et al.
·
Journal of Thoracic Oncology
·
91
PDF
Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib
2017
·
Ryo Ariyasu
, Atsushi Horiike
, et al.
·
Anti-Cancer Drugs
·
23
Small-cell lung cancer: current therapy and novel agents.
2005
·
Atsushi Horiike
, Nagahiro Saijo
·
PubMed
·
11
Topoisomerase I inhibitors in small-cell lung cancer. The Japanese experience.
2004
·
Nagahiro Saijo
, Atsushi Horiike
·
PubMed
·
5
A Phase II Study of Erlotinib as First-Line Treatment in Japanese Advanced NSCLC Patients Harboring EGFR Mutations
2012
·
A. Horiike
, M. Nishio
, et al.
·
Annals of Oncology
·
4
[A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib].
2011
·
Noriko Yanagitani
, Atsushi Horiike
, et al.
·
PubMed
·
3
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study
2025
·
Risako Suzuki
, Ryotaro Ohkuma
, et al.
·
Biomedicines
·
2
PDF
Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial
2026
·
Domenica Lorusso
, Jérôme Martin-Babau
, et al.
·
The Lancet
·
1
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma
2017
·
Y. Okuma
, Y. Goto
, et al.
·
Annals of Oncology
·
1
Differential efficacy of pemetrexed in nonsquamous NSCLC based on human cytokeratin fragment antigen 21-1 (CYFRA21-1) serum levels.
2011
·
K. Kaburaki
, A. Horiike
, et al.
·
Journal of Clinical Oncology
·
1
Treatment of Small Cell Lung Cancer
2003
·
Atsushi Horiike
, Nagahiro Saijo
·
Cancer Research and Treatment
·
1
PDF
Supplementary Data1 from Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Advanced Non–Small Cell Lung Cancer with ≥50% PD-L1 Expression: A Nonrandomized Phase II Trial
2026
·
Atsushi Horiike
, Hiroshi Wakui
, et al.
Data from Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Advanced Non–Small Cell Lung Cancer with ≥50% PD-L1 Expression: A Nonrandomized Phase II Trial
2026
·
Atsushi Horiike
, Hiroshi Wakui
, et al.
Figure S1 from Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Advanced Non–Small Cell Lung Cancer with ≥50% PD-L1 Expression: A Nonrandomized Phase II Trial
2026
·
Atsushi Horiike
, Hiroshi Wakui
, et al.
Chemotherapy-associated hyponatremia during curative-intent salvage therapy for very late relapse of central nervous system germinoma: a case-based review
2026
·
Ryotaro Ohkuma
, Toshiaki Tsurui
, et al.
·
Journal of Cancer Research and Clinical Oncology
Association of Prior Local Therapy with Outcomes Within Systemic Therapy Regimen Cohorts in Advanced Soft Tissue Sarcoma: A Retrospective Cohort Study
2026
·
Ryotaro Ohkuma
, Tomoyuki Ishiguro
, et al.
·
Cancers
Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Advanced Non–Small Cell Lung Cancer with ≥50% PD-L1 Expression: A Nonrandomized Phase II Trial
2026
·
Atsushi Horiike
, Hiroshi Wakui
, et al.
·
Clinical Cancer Research
Serum microRNA in arterial versus venous blood in lung cancer
2026
·
Toshiaki Tsurui
, Naoya Himuro
, et al.
·
SSRN Electronic Journal
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study
2025
·
Hirotsugu Ariizumi
, Miyuki Shimazui
, et al.
·
Frontiers in Immunology
PDF
PD-L1高発現の未治療非小細胞肺癌におけるPembrolizumabの有効性とSTK-11/LKB1発現の検討
2019
·
Hasegawa Tsukasa
, Yanagitani Noriko
, et al.
·
Haigan
以前に治療された進行性非小細胞肺癌の日本人患者におけるアテゾリズマブ:第3相オーク試験のサブグループ分析【jst・京大機械翻訳】
2018
·
Toyoaki Hida
, Reiko Kaji
, et al.
·
Clinical Lung Cancer
ALK融合遺伝子を有するNSCLCにおけるPK/PGxとクリゾチニブ毒性との関連:多施設研究
2015
·
Yukiko Nakamura
, Yamada Kazuhiko
, et al.
·
Haigan
A Case of Multiple Cutaneous Metastasis of Lung Cancer to the Finger
2011
·
Hisashi Tanaka
, Keita Kudo
, et al.
·
Haigan
PDF
Detection of epidermal growth factor receptor mutation in transbronchial aspiration cytology of non-small cell lung cancer
2006
·
A. Horiike
, H. Kimura
, et al.
·
Journal of Clinical Oncology
P-629 A phase I study of erlotinib (TarcevaTM) monotherapy in Japanese patients with non-small cell lung cancer and other solid tumors
2003
·
Horiike Atsushi
, Yasuhide Yamada
, et al.
·
Lung Cancer
Show more works
View as search
Works count:
25
Citation count:
143
H-index:
4
I10-index:
3
Year
Topic
Type